Literature DB >> 27364150

Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT.

Eun Young Kim1, Young Saing Kim2, Inkeun Park3, Hee Kyung Ahn3, Eun Kyung Cho3, Yu Mi Jeong1, Jeong Ho Kim1.   

Abstract

BACKGROUND: Single cross-sectional area of muscle at the third lumbar vertebra (L3MA) is gold standard to estimate skeletal muscle mass (SMM), and L3 muscle index (L3MI, L3MA/height(2)) is used to determine sarcopenia. The purposes of this study were to evaluate the relationship between SMM indices determined by routine chest CT and L3MI in patients with small-cell lung cancer (SCLC) and to suggest chest CT-derived diagnostic criteria for sarcopenia.
METHODS: Area of pectoralis muscles at the aortic arch (PMA) and at L1 (L1MA) was retrospectively measured on chest CT images of 90 consecutive SCLC patients. Pearson's correlation and multiple linear regression analysis were used to assess relationships between L3MI determined by PET/CT and pectoralis muscle index (PMI) and L1 muscle index (L1MI) determined by chest CT.
RESULTS: The correlation between L1MI and L3MI was stronger than that between PMI and L3MI (r = 0.851 vs. r = 0.447, p < 0.001). Multivariable regression analysis showed that L1MI was the only significant predictor of L3MI; L3MI = 0.963 × L1MI + 10.336 (R (2)  = 0.689, p < 0.001) for male and L3MI = 0.772 × L1MI + 16.518 (R (2)  = 0.777, p < 0.001) for female. Using this relationship, estimated cutoffs of L1MI for sarcopenia were 46 cm(2)/m(2) for male and 29 cm(2)/m(2) for female (L3MI cutoffs for sarcopenia are 55 cm(2)/m(2) for male and 39 cm(2)/m(2) for female). The sensitivity and specificity of L1MI cutoffs to determine sarcopenia were 98.2 and 100 %, respectively.
CONCLUSIONS: Chest CT-determined L1MI is highly correlated with L3MI in SCLC patients. L1MI, as determined by chest CT, could be used to determine the presence of sarcopenia with suggested cutoffs of 46 cm(2)/m(2) for men and 29 cm(2)/m(2) for women.

Entities:  

Keywords:  Cancer cachexia; Sarcopenia; Skeletal muscle mass; Small-cell lung cancer; Tomography; X-ray computed

Mesh:

Year:  2016        PMID: 27364150     DOI: 10.1007/s00520-016-3321-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  15 in total

1.  Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.

Authors:  N Mitsiopoulos; R N Baumgartner; S B Heymsfield; W Lyons; D Gallagher; R Ross
Journal:  J Appl Physiol (1985)       Date:  1998-07

2.  Modern staging of small cell lung cancer.

Authors:  Gregory P Kalemkerian; Shirish M Gadgeel
Journal:  J Natl Compr Canc Netw       Date:  2013-01-01       Impact factor: 11.908

3.  Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer.

Authors:  Eun Young Kim; Young Saing Kim; Inkeun Park; Hee Kyung Ahn; Eun Kyung Cho; Yu Mi Jeong
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

Review 4.  Definition and classification of cancer cachexia: an international consensus.

Authors:  Kenneth Fearon; Florian Strasser; Stefan D Anker; Ingvar Bosaeus; Eduardo Bruera; Robin L Fainsinger; Aminah Jatoi; Charles Loprinzi; Neil MacDonald; Giovanni Mantovani; Mellar Davis; Maurizio Muscaritoli; Faith Ottery; Lukas Radbruch; Paula Ravasco; Declan Walsh; Andrew Wilcock; Stein Kaasa; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2011-02-04       Impact factor: 41.316

5.  Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.

Authors:  Lisa Martin; Laura Birdsell; Neil Macdonald; Tony Reiman; M Thomas Clandinin; Linda J McCargar; Rachel Murphy; Sunita Ghosh; Michael B Sawyer; Vickie E Baracos
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

6.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

7.  Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.

Authors:  Carla M M Prado; Vickie E Baracos; Linda J McCargar; Tony Reiman; Marina Mourtzakis; Katia Tonkin; John R Mackey; Sheryl Koski; Edith Pituskin; Michael B Sawyer
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

8.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.

Authors:  Carla M M Prado; Jessica R Lieffers; Linda J McCargar; Tony Reiman; Michael B Sawyer; Lisa Martin; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2008-06-06       Impact factor: 41.316

9.  A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.

Authors:  Marina Mourtzakis; Carla M M Prado; Jessica R Lieffers; Tony Reiman; Linda J McCargar; Vickie E Baracos
Journal:  Appl Physiol Nutr Metab       Date:  2008-10       Impact factor: 2.665

10.  Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.

Authors:  Judith Meza-Junco; Aldo J Montano-Loza; Vickie E Baracos; Carla M M Prado; Vincent G Bain; Crystal Beaumont; Nina Esfandiari; Jessica R Lieffers; Michael B Sawyer
Journal:  J Clin Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 3.062

View more
  17 in total

1.  Machine Learning for Automatic Paraspinous Muscle Area and Attenuation Measures on Low-Dose Chest CT Scans.

Authors:  Ryan Barnard; Josh Tan; Brandon Roller; Caroline Chiles; Ashley A Weaver; Robert D Boutin; Stephen B Kritchevsky; Leon Lenchik
Journal:  Acad Radiol       Date:  2019-07-17       Impact factor: 3.173

2.  Determination of Low Muscle Mass by Muscle Surface Index of the First Lumbar Vertebra Using Low-Dose Computed Tomography.

Authors:  Ping-Huai Wang; Chien-Hung Gow; Yen-Ling Chiu; Tien-Chi Li
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

3.  A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer.

Authors:  Bjørn H Grønberg; Bjørg Sjøblom; Tore Wentzel-Larsen; Vickie E Baracos; Marianne J Hjermstad; Nina Aass; Roy M Bremnes; Øystein Fløtten; Asta Bye; Marit Jordhøy
Journal:  Eur J Clin Nutr       Date:  2018-09-25       Impact factor: 4.016

4.  Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).

Authors:  Alejandro Recio-Boiles; Jose N Galeas; Bernard Goldwasser; Karla Sanchez; Louise M W Man; Ryan D Gentzler; Jane Gildersleeve; Patricia J Hollen; Richard J Gralla
Journal:  Support Care Cancer       Date:  2018-02-07       Impact factor: 3.603

5.  Clinical significance of the cachexia index in patients with small cell lung cancer.

Authors:  Se-Il Go; Mi Jung Park; Gyeong-Won Lee
Journal:  BMC Cancer       Date:  2021-05-17       Impact factor: 4.430

6.  Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non-small cell lung cancer.

Authors:  Kazutaka Kakinuma; Hazime Tsuruoka; Kei Morikawa; Naoki Furuya; Takeo Inoue; Teruomi Miyazawa; Masamichi Mineshita
Journal:  Thorac Cancer       Date:  2017-10-25       Impact factor: 3.500

7.  Association of Chest CT-Based Quantitative Measures of Muscle and Fat with Post-Lung Transplant Survival and Morbidity: A Single Institutional Retrospective Cohort Study in Korean Population.

Authors:  Young Hoon Cho; Kyung Hyun Do; Eun Jin Chae; Se Hoon Choi; Kyung Wook Jo; Sang Oh Lee; Sang Bum Hong
Journal:  Korean J Radiol       Date:  2019-03       Impact factor: 3.500

8.  Tumor Transcriptome Reveals High Expression of IL-8 in Non-Small Cell Lung Cancer Patients with Low Pectoralis Muscle Area and Reduced Survival.

Authors:  Sarah Santiloni Cury; Diogo de Moraes; Paula Paccielli Freire; Grasieli de Oliveira; Douglas Venâncio Pereira Marques; Geysson Javier Fernandez; Maeli Dal-Pai-Silva; Érica Nishida Hasimoto; Patricia Pintor Dos Reis; Silvia Regina Rogatto; Robson Francisco Carvalho
Journal:  Cancers (Basel)       Date:  2019-08-26       Impact factor: 6.639

9.  Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.

Authors:  Xing Dong; Xu Dan; Ao Yawen; Xu Haibo; Li Huan; Tu Mengqi; Chen Linglong; Ruan Zhao
Journal:  Thorac Cancer       Date:  2020-08-06       Impact factor: 3.500

10.  Sarcopenia Detection System Using RGB-D Camera and Ultrasound Probe: System Development and Preclinical In-Vitro Test.

Authors:  Yeoun-Jae Kim; Seongjun Kim; Jaesoon Choi
Journal:  Sensors (Basel)       Date:  2020-08-09       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.